van Kamp GJ - Search Results

1

Selection of monoclonal antibody E48 IgG or U36 IgG for adjuvant radioimmunotherapy in head and neck cancer patients.

de Bree R, Roos JC, Plaizier MA, Quak JJ, van Kamp GJ, den Hollander W, Snow GB, van Dongen GA. de Bree R, et al. Among authors: van kamp gj, van dongen ga. Br J Cancer. 1997;75(7):1049-60. doi: 10.1038/bjc.1997.179. Br J Cancer. 1997. PMID: 9083342 Free PMC article.

2

Phase I therapy study of 186Re-labeled chimeric monoclonal antibody U36 in patients with squamous cell carcinoma of the head and neck.

Colnot DR, Quak JJ, Roos JC, van Lingen A, Wilhelm AJ, van Kamp GJ, Huijgens PC, Snow GB, van Dongen GA. Colnot DR, et al. Among authors: van kamp gj, van dongen ga, van lingen a. J Nucl Med. 2000 Dec;41(12):1999-2010. J Nucl Med. 2000. PMID: 11138685 Free article. Clinical Trial.

3

Carcinoembryonic antigen and head and neck cancer.

Laarman DA, van Kamp GJ, Balm AJ, Braakhuis BJ, Snow GB. Laarman DA, et al. Among authors: van kamp gj. Clin Otolaryngol Allied Sci. 1991 Apr;16(2):182-6. doi: 10.1111/j.1365-2273.1991.tb01973.x. Clin Otolaryngol Allied Sci. 1991. PMID: 2070537 Clinical Trial.

4

Polymorphic epithelial mucin (MUC-1)-containing circulating immune complexes in carcinoma patients.

Gourevitch MM, von Mensdorff-Pouilly S, Litvinov SV, Kenemans P, van Kamp GJ, Verstraeten AA, Hilgers J. Gourevitch MM, et al. Among authors: van kamp gj. Br J Cancer. 1995 Oct;72(4):934-8. doi: 10.1038/bjc.1995.436. Br J Cancer. 1995. PMID: 7547243 Free PMC article.

5

Minor human antibody response to a mouse and chimeric monoclonal antibody after a single i.v. infusion in ovarian carcinoma patients: a comparison of five assays.

Buist MR, Kenemans P, van Kamp GJ, Haisma HJ. Buist MR, et al. Among authors: van kamp gj. Cancer Immunol Immunother. 1995 Jan;40(1):24-30. doi: 10.1007/BF01517232. Cancer Immunol Immunother. 1995. PMID: 7828165 Free PMC article.

6

Carcinoma-associated mucin serum markers CA M26 and CA M29: efficacy in detecting and monitoring patients with cancer of the breast, colon, ovary, endometrium and cervix.

Yedema KA, Kenemans P, Wobbes T, van Kamp GJ, de Bruijn HW, Thomas CM, Massuger LF, Schijf CP, Bon GG, Vermorken JB, et al. Yedema KA, et al. Among authors: van kamp gj. Int J Cancer. 1991 Jan 21;47(2):170-9. doi: 10.1002/ijc.2910470203. Int J Cancer. 1991. PMID: 1988362

7

The use of biliary CEA measurements in the diagnosis of recurrent colorectal cancer.

Paul MA, Visser JJ, Mulder C, van Kamp GJ, Cuesta MA, Meijer S. Paul MA, et al. Among authors: van kamp gj. Eur J Surg Oncol. 1997 Oct;23(5):419-23. doi: 10.1016/s0748-7983(97)93722-7. Eur J Surg Oncol. 1997. PMID: 9393570

8

CA 125: fundamental and clinical aspects.

Verheijen RH, von Mensdorff-Pouilly S, van Kamp GJ, Kenemans P. Verheijen RH, et al. Among authors: van kamp gj. Semin Cancer Biol. 1999 Apr;9(2):117-24. doi: 10.1006/scbi.1998.0114. Semin Cancer Biol. 1999. PMID: 10202133 Review.

9

CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery.

Yedema CA, Kenemans P, Thomas CM, Massuger LF, Wobbes T, Verstraeten R, van Kamp GJ, Hilgers J. Yedema CA, et al. Among authors: van kamp gj. Eur J Cancer. 1993;29A(7):966-71. doi: 10.1016/s0959-8049(05)80203-5. Eur J Cancer. 1993. PMID: 8499150

10

Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours.

von Mensdorff-Pouilly S, Gourevitch MM, Kenemans P, Verstraeten AA, Litvinov SV, van Kamp GJ, Meijer S, Vermorken J, Hilgers J. von Mensdorff-Pouilly S, et al. Among authors: van kamp gj. Eur J Cancer. 1996 Jul;32A(8):1325-31. doi: 10.1016/0959-8049(96)00048-2. Eur J Cancer. 1996. PMID: 8869094

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

124 results

Search Page